{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:18:55Z","timestamp":1791119935648,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.autrev.2025.103858","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T11:21:47Z","timestamp":1750677707000},"page":"103858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact and management of warm autoimmune haemolytic anaemia associated with systemic lupus erythematosus"],"prefix":"10.1016","volume":"24","author":[{"given":"Guillermo J.","family":"Pons-Estel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Zazzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Murakhovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103858_bb0005","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.semarthrit.2015.11.003","article-title":"Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: data from a multiethnic Latin American cohort","volume":"45","author":"Gonzalez-Naranjo","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103858_bb0010","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.24020","article-title":"Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort","volume":"59","author":"Duran","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103858_bb0015","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1177\/0961203319877245","article-title":"Autoimmune haemolytic anaemia and thrombocytopaenia in a single-centre cohort of patients with systemic lupus erythematosus from Turkey: clinical associations and effect on disease damage and survival","volume":"28","author":"Artim-Esen","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103858_bb0020","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/blood.2019003808","article-title":"How I treat warm autoimmune hemolytic anemia","volume":"137","author":"Barcellini","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2025.103858_bb0025","doi-asserted-by":"crossref","first-page":"1180509","DOI":"10.3389\/fimmu.2023.1180509","article-title":"The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?","volume":"14","author":"Berentsen","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103858_bb0030","series-title":"Immune Hemolytic Anemias","author":"Petz","year":"2004"},{"key":"10.1016\/j.autrev.2025.103858_bb0035","first-page":"25","article-title":"Autoimmune hemolytic anemias: classifications, pathophysiology, diagnoses and management","author":"Loriamini","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103858_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting","volume":"41","author":"J\u00e4ger","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.autrev.2025.103858_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.blre.2012.01.002","article-title":"Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia","volume":"26","author":"Berentsen","year":"2012","journal-title":"Blood Rev"},{"key":"10.1016\/j.autrev.2025.103858_bb0050","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMcp1900554","article-title":"Warm autoimmune hemolytic anemia","volume":"381","author":"Brodsky","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2025.103858_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000078","article-title":"Haematological manifestations of lupus","volume":"2","author":"Fayyaz","year":"2015","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2025.103858_bb0060","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/BOR.0000000000000523","article-title":"Autoimmune haemolytic anaemia and autoimmune thrombocytopenia in childhood-onset systemic lupus erythematosus: updates on pathogenesis and treatment","volume":"30","author":"Neely","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103858_bb0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/ard.2005.041673","article-title":"Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment","volume":"65","author":"Giannouli","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103858_bb0070","doi-asserted-by":"crossref","first-page":"220","DOI":"10.7326\/0003-4819-86-2-220","article-title":"Hematologic aspects of systemic lupus erythematosus: current concepts","volume":"86","author":"Budman","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2025.103858_bb0075","first-page":"74","article-title":"IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein","volume":"115","author":"Victoria","year":"1990","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.autrev.2025.103858_bb0080","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1111\/trf.15911","article-title":"Differential red blood cell age fractionation and band 3 phosphorylation distinguish two different subtypes of warm autoimmune hemolytic anemia","volume":"60","author":"Bloch","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.autrev.2025.103858_bb0085","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMra2033982","article-title":"Autoimmune hemolytic anemias","volume":"385","author":"Berentsen","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2025.103858_bb0090","article-title":"Methods to evaluate the potential clinical significance of antibodies to red blood cells","volume":"2","author":"Boligan","year":"2022","journal-title":"Curr Protoc"},{"key":"10.1016\/j.autrev.2025.103858_bb0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2025.103858_bb0100","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/096120339700600806","article-title":"Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus","volume":"6","author":"Lang","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103858_bb0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0002-9343(99)00413-1","article-title":"Autoimmune hemolytic anemia in patients with systemic lupus erythematosus","volume":"108","author":"Kokori","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2025.103858_bb0110","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1046\/j.1365-2141.2002.03729.x","article-title":"Detection of lupus anticoagulant identifies patients with autoimmune haemolytic anaemia at increased risk for venous thromboembolism","volume":"118","author":"Pullarkat","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2025.103858_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102913","article-title":"Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"21","author":"Bernardoff","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103858_bb0120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/0961203308090990","article-title":"Haemolytic anaemia in a multi-ethnic cohort of lupus patients: a clinical and serological perspective","volume":"17","author":"Jeffries","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103858_bb0125","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103858_bb0130","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103858_bb0135","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103858_bb0140","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/acr.22583","article-title":"Distinctions between diagnostic and classification criteria?","volume":"67","author":"Aggarwal","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2025.103858_bb0145","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.3390\/jcm9123859","article-title":"New insights in autoimmune hemolytic anemia: from pathogenesis to therapy stage 1","volume":"9","author":"Barcellini","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2025.103858_bb0150","unstructured":"Barcellini W. Diagnosis of hemolytic anemia in adults; 2022. [accessed September 25, 2023] https:\/\/www.uptodate.com\/contents\/diagnosis-of-hemolytic-anemia-in-adults."},{"key":"10.1016\/j.autrev.2025.103858_bb0155","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1182\/blood-2014-06-583021","article-title":"Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients","volume":"124","author":"Barcellini","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2025.103858_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207218","article-title":"Venous thromboembolic events during warm autoimmune hemolytic anemia","volume":"13","author":"Audia","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2025.103858_bb0165","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1002\/ajh.25212","article-title":"Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers","volume":"93","author":"Barcellini","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.autrev.2025.103858_bb0170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.md.0000224709.70133.f7","article-title":"Predictors of survival in systemic lupus erythematosus","volume":"85","author":"Kasitanon","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2025.103858_bb0175","first-page":"2101","article-title":"Outcomes of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: a nationwide inpatient sample study","volume":"74","author":"Turk","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103858_bb0180","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/09612033231163745","article-title":"Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: data from a multiethnic Latin American cohort","volume":"32","author":"Gonzalez","year":"2023","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103858_bb0185","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1177\/0961203316672926","article-title":"Active haematological manifestations of systemic lupus erythematosus lupus are associated with a high rate of in-hospital mortality","volume":"26","author":"Miranda-Hernandez","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103858_bb0190","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0961203316676379","article-title":"Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients","volume":"26","author":"Gormezano","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103858_bb0195","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/acr.24900","article-title":"Predictors of thirty-day hospital readmissions in systemic lupus erythematosus in the United States: a nationwide study","volume":"75","author":"Najjar","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2025.103858_bb0200","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1111\/bjh.17217","article-title":"Developing the evidence base for the management of autoimmune haemolytic anaemia (AIHA): the UK experience","volume":"192","author":"Hill","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2025.103858_bb0205","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/annrheumdis-2022-eular.2607","article-title":"POS1428 identification of a warm autoimmune hemolytic anemia (wAHIA) population using predictive analytics of a known clinically profiled cohort","volume":"81","author":"Mccrae","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103858_bb0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103858_bb0215","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/annrheumdis-2018-213512","volume":"77","author":"Pons-Estel","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103858_bb0220","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kex286","article-title":"The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults","volume":"57","author":"Gordon","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103858_bb0225","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1136\/annrheumdis-2011-200831","article-title":"Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials","volume":"71","author":"Manzi","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103858_bb0230","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1191\/0961203306lu2292oa","article-title":"Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases","volume":"15","author":"Gomard-Mennesson","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103858_bb0235","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1177\/0961203310395802","article-title":"Assessment of flares in lupus patients enrolled in a phase II\/III study of rituximab (EXPLORER)","volume":"20","author":"Merrill","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103858_bb0240","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ajh.24999","article-title":"Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: a multicenter retrospective cohort study of 71 adults","volume":"93","author":"Serris","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.autrev.2025.103858_bb0245","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/rheumatology\/keu393","article-title":"Successful treatment of warm-type haemolytic anaemia with bortezomib in a rituximab-failed systemic lupus erythematosus patient","volume":"54","author":"Wang","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103858_bb0250","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1177\/0961203319881500","article-title":"Successful treatment of systemic lupus erythematosus-related refractory autoimmune hemolytic anemia with ofatumumab","volume":"28","author":"Poulet","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103858_bb0255","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/rheumatology\/kew267","article-title":"Successful treatment of life-threatening autoimmune haemolytic anaemia with ofatumumab in a patient with systemic lupus erythematosus","volume":"55","author":"Karageorgas","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103858_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5583","article-title":"Refractory autoimmune hemolytic anemia in a systemic lupus erythematosus patient: a clinical case report","volume":"10","author":"Crawford","year":"2022","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.autrev.2025.103858_bb0265","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJMoa2023325","article-title":"Targeting CD38 with daratumumab in refractory systemic lupus erythematosus","volume":"383","author":"Ostendorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2025.103858_bb0270","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1191\/0961203305lu2163cr","article-title":"Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus","volume":"14","author":"Mak","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103858_bb0275","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1191\/0961203303lu419cr","article-title":"Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"12","author":"Alba","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103858_bb0280","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/rheumatology\/kes072","article-title":"Tocilizumab for treating refractory haemolytic anaemia in a patient with systemic lupus erythematosus","volume":"51","author":"Garcia-Hernandez","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103858_bb0285","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1191\/0961203305lu2090cr","article-title":"Systemic lupus erythematosus with refractory hemolytic anemia effectively treated with cyclosporin A: a case report","volume":"14","author":"Wang","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103858_bb0290","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1620\/tjem.208.355","article-title":"Effective treatment with cyclosporine A of a child with systemic lupus erythematosus resistant to cyclophosphamide pulse therapy","volume":"208","author":"Suzuki","year":"2006","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.autrev.2025.103858_bb0295","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ajh.2830440404","article-title":"Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients","volume":"44","author":"Flores","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1016\/j.autrev.2025.103858_bb0300","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2024-eular.2627","article-title":"POS0024\u00a0improvement of hematological parameters during long-term anifrolumab treatment and association with week 52 BICLA response","volume":"83","author":"Vital","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103858_bb0305","article-title":"Efficacy of whole-blood exchange transfusion in refractory severe autoimmune haemolytic anaemia secondary to systemic lupus erythematosus: a real-world observational retrospective study","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103858_bb0310","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/annrheumdis-2015-eular.6393","article-title":"AB0523 splenectomy in systemic lupus erythematosus versus autoimmune hematological diseases: to late or to early?","volume":"74","author":"Barron","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103858_bb0315","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.26508","article-title":"Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: phase 2, multicenter, open-label study","volume":"97","author":"Kuter","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.autrev.2025.103858_bb0320","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.HS9.0000561876.96057.48","article-title":"S899 inhibition of C3 with APL-2 controls haemolysis and increases haemoglobin levels in subjects with autoimmune haemolytic anaemia (AIHA)","volume":"3","author":"Gertz","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.autrev.2025.103858_bb0325","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.ekir.2023.08.033","article-title":"Clinical safety and efficacy of pegcetacoplan in a phase 2 study of patients with C3 glomerulopathy and other complement-mediated glomerular diseases","volume":"8","author":"Dixon","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2025.103858_bb0330","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ajh.27144","article-title":"Fostamatinib for warm antibody autoimmune hemolytic anemia: phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD)","volume":"99","author":"Kuter","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.autrev.2025.103858_bb0335","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1182\/blood-2024-200325","article-title":"Part a efficacy and safety of oral Bruton tyrosine kinase inhibitor (BTKi) rilzabrutinib in patients with warm autoimmune hemolytic anemia (wAIHA): multicenter, open-label, phase 2b study","volume":"144","author":"Cooper","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2025.103858_bb0340","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207937","article-title":"Safety and efficacy of nipocalimab in patients with generalized myasthenia gravis: results from the randomized phase 2 Vivacity-MG study","volume":"102","author":"Antozzi","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103858_bb0345","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1474-4422(24)00498-8","article-title":"Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"24","author":"Antozzi","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2025.103858_bb0350","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood-2018-99-119468","article-title":"Inhibition of C3 with APL-2 results in normalisation of markers of intravascular and extravascular hemolysis in patients with autoimmune hemolytic anemia (AIHA)","volume":"132","author":"Grossi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2025.103858_bb0355","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/biomedicines12071597","article-title":"Anti-B-cell-activating factor (BAFF) therapy: a novel addition to autoimmune disease management and potential for immunomodulatory therapy in warm autoimmune hemolytic anemia","volume":"12","author":"Cheekati","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.autrev.2025.103858_bb0360","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.4049\/jimmunol.2001130","article-title":"Preclinical efficacy and anti-inflammatory mechanisms of action of the Bruton tyrosine kinase inhibitor rilzabrutinib for immune-mediated disease","volume":"206","author":"Langrish","year":"2021","journal-title":"J Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:06:17Z","timestamp":1762553177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225001181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1568997225001181"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103858","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact and management of warm autoimmune haemolytic anaemia associated with systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103858"}}